Explore a focused selection of standout past IPO performers across BSE SME, BSE Mainboard, NSE SME and NSE Mainboard.
| Company | Listing Date | Issue Price | Listing Gain (approx.) | CMP (approx.) | Gain from Issue Price | Notes |
|---|---|---|---|---|---|---|
| Cryogenic OGS | 10 Jul 2025 | ₹47 | ~90% | ₹370 | ~690% | Excellent follow-through |
| Anondita Medicare | 1 Sep 2025 | ₹145 | ~90% | ₹1,060–1,078 | 630–640%+ | Strong sustained multi-bagger |
| Zelio E-Mobility | 8 Oct 2025 | ₹136 | ~14% | ₹864 | ~535% | Modest listing, very strong post-listing |
Excellent follow-through
Strong sustained multi-bagger
Modest listing, very strong post-listing
| Company | Listing Date | Issue Price | Listing Gain (approx.) | CMP (approx.) | Gain from Issue Price | Notes |
|---|---|---|---|---|---|---|
| Tempsens Instruments (India) | 28 Aug 2026 | ₹300 | +95–111% | ₹570–575 | +90% | Best listing of recent period; still holding strong gains |
Best listing of recent period; still holding strong gains
| Company | Listing Date | Issue Price | Listing Gain (approx.) | CMP (approx.) | Gain from Issue Price | Notes |
|---|---|---|---|---|---|---|
| Anondita Medicare | 1 Sep 2025 | ₹145 | ~90% | ₹1,060–1,095 | 630–655% | One of the strongest multi-baggers; listed on NSE Emerge |
| Zelio E-Mobility | 8 Oct 2025 | ₹136 | ~14% | ₹850–865 | ~525–535% | Modest listing but excellent post-listing growth |
One of the strongest multi-baggers; listed on NSE Emerge
Modest listing but excellent post-listing growth
| Company | Listing Date | Issue Price | Listing Gain (approx.) | CMP (approx.) | Gain from Issue Price | Notes |
|---|---|---|---|---|---|---|
| Tempsens Instruments (India) | 28 Aug 2026 | ₹300 | +95–111% | ₹570–575 | +90% | Best recent listing; still holding strong gains |
| Behari Lal Engineering | 19 Aug 2026 | ₹285 | +63–76% | ₹450–500 | +55–75% | High listing gain with continued strength |
Best recent listing; still holding strong gains
High listing gain with continued strength
Review the past performance categories, then explore the advisory plan or request a free consultation.
